|国家预印本平台
首页|从脾论治免疫性血小板减少性紫癜的理论基础与临床实践

从脾论治免疫性血小板减少性紫癜的理论基础与临床实践

heoretical Foundation and Clinical Practice on Immune Thrombocytopenic Purpura Treated through the Methods of Regulation the Spleen in TCM

中文摘要英文摘要

免疫性血小板减少性紫癜是一种自身免疫性疾病.多数患者起病以全身皮肤黏膜紫癜为首发症状,常反复发作,经久缠绵,其病机与中医学的脾虚不能摄血密切相关。本文从理论基础及临床实践两方面分析了从脾论治ITP的有效性。基础理论方面,通过阅读大量的古代文献,论述了中医"脾"脏象与现代医学解剖的"脾脏"部分概念的融合,并从生理、病理与治疗角度提出了从脾论治的理论依据与可行性。在实践方面,通过检索与整理近五年相关文献,分析了中医药治疗ITP的临床资料,发现从脾论治的诊疗思路及其方药能明显改善患者临床症状、舒缓出血倾向,展示了从脾论治ITP的独特优势与应用前景。

Immune thrombocytopenic purpura is autoimmune disease. In the most of patients, the first discovered symptom is that the purpura appears on skin all over the body. The pathogenesis of repeated bleeding and long disease course is related to failure in controlling blood caused by spleen deficiency in TCM. According to this, we analyze the regulation in ITP treatment in the way of theory and practice in this article. In basic theory, we find that the concept of "Pi-Zang organ" in TCM and "spleen" in modern medicine has a same part on the base of many classical ancient literature, and we analyze the feasibility in treating ITP from spleen deficiency by the way of pathology, physiology and therapy. On the other hand, by exploring the clinical data of ITP in recent 5years, we find that the ITP patients who were diagnosed and treated from spleen in TCM have more clinical improvements and less bleeding problems. So , advantages in treating ITP from spleen are worth exploring.

陈信义、张雅月、侯丽、李天天

中医学内科学基础医学

中西医结合临床免疫性血小板减少性紫癜脾脏

raditional Chinese MedicineImmune thrombocytopenic purpuraspleen

陈信义,张雅月,侯丽,李天天.从脾论治免疫性血小板减少性紫癜的理论基础与临床实践[EB/OL].(2014-05-26)[2025-08-11].http://www.paper.edu.cn/releasepaper/content/201405-467.点此复制

评论